Immune to Cancer: The CRI Blog
-
Alexis and the Young Philanthropists
Since 2008, Alexis Feldman has led a group of highly motivated young New York City professionals who…
-
Knowledge is Love
Spread the word about immunotherapy this Valentine's Day.
-
Immune Checkpoint Inhibitors: What’s Next?
What’s ahead beyond CTLA-4 and PD-1?
-
World Cancer Day: The Many Languages of Cure
From Bengali to Ukrainian, our scientists have one goal: to find a cure for all cancers within…
-
What’s in a Name?
Cancer immunotherapies can have some mind-boggling names. But there’s a reason for it all.
-
Progress Report from the Cancer Immunology “Dream Team”
A group of "star" scientists are investigating new avenues of cancer immunotherapy that will benefit patients.
-
Do Something Epic in 2015!
Meet a few of the riders who will join Team CRI in the 2015 Ride to Conquer…
-
Patient Story Featured at World Cancer Congress
The inspiring story of lung cancer survivor Pam G. put a human face on cancer immunotherapy.
-
Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer
The results of a phase III trial are clear: the PD-1 checkpoint inhibitor nivolumab improves survival for…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.